The Directors of DataDot Technology Limited (ASX:DDT) announce that AgTechnix Pty Ltd, the joint initiative company owned by DDT and Ipeco Pty Limited, has entered into a commercial arrangement with GlaxoSmithKline Australia Pty Limited (GSK) to use IntelliSeed™ on a commercial quantity of poppy seed to be sown by GSK in the 2010 season.
Intelliseed™ is a patented track and trace technology allowing seeds, grain and other bulk commodities to be identified accurately and cost effectively, right down to an individual batch number, so providing both detection of counterfeit target commodities and a control mechanism for internal or cross border, end-to-end supply chain management. Counterfeiting results in losses to plant breeders and agricultural and horticultural producers world-wide.
From Tasmania, GSK supplies approximately 25% of the global poppy market with opiate derived products from the cultivation of poppies. The decision by GSK to use IntelliSeed™ will enhance the value of this export product by adding supply chain security, visibility, seed authentication, “in soil” identification and seeding rate validation techniques that have been previously unavailable at this level to the global seed industry.
Mr Ben Bootle, CEO of DDT, said that AgTechnix welcomes the opportunity to partner the application of IntelliSeed™ with GSK, a recognised in-field technology leader in commercial poppy production. Mr Rohan Kile, Crop Supply Manager of GSK, said that IntelliSeed™ is a logical next step in extending the company’s already high service levels to its Tasmanian network of contracted growers. It will provide seed authentication at all levels of the supply chain from seed production to final sowing.
Contact Information:
DataDot Technology Limited
Ben Bootle – CEO
bbootle@datadotdna.com
+61 (0)2 8977 4900
AgTechnix Pty Limited.
Neil Mulcahy – CEO
nmulcahy@agtechnix.com
+61 (0)3 97751313
Glaxo-Smith-Kline Australia Pty Limited
Rohan Kile
Crop Supply Manager
rohan.g.kile@gsk.com
